Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Title:Editorial (Thematic Issue: Nutrition and Immunology in Diabetes, Cancer and Infectious Diseases)
Volume: 14 Issue: 1
Author(s): Dra. C. Rebeca Monroy Torres
Affiliation:
Export Options
About this article
Cite this article as:
Monroy Torres C. Rebeca Dra., Editorial (Thematic Issue: Nutrition and Immunology in Diabetes, Cancer and Infectious Diseases), Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) 2014; 14 (1) . https://dx.doi.org/10.2174/187152221401140812144142
DOI https://dx.doi.org/10.2174/187152221401140812144142 |
Print ISSN 1871-5222 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6115 |
Related Books
22
Related Articles
-
Cell Therapy for the Treatment of Chronic Ischemic Heart Disease
Current Pharmaceutical Design Potent Chemopreventive Agents Against Pancreatic Cancer
Current Cancer Drug Targets Tityus serrulatus Scorpion Venom and Toxins: An Overview
Protein & Peptide Letters Acute Toxicological and Histopathological Elucidation of <i>Rheum emodi</i> Rhizome Extract to Demonstrate Antidiabetic Activity in Alloxan-induced Diabetic Rats
Current Bioactive Compounds Pharmacological Management of Type 2 Diabetes Mellitus: An Update
Current Diabetes Reviews Liver-Enriched Transcription Factors and Their Role in Regulating UDP Glucuronosyltransferase Gene Expression
Current Drug Metabolism Electroporation-Enhanced Nonviral Gene Transfer for the Prevention or Treatment of Immunological, Endocrine and Neoplastic Diseases
Current Gene Therapy HLA-G Expression in Cancers: Potential Role in Diagnosis, Prognosis and Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Peroxisome Proliferator-Activated Receptors: The Nutritionally Controlled Molecular Networks that Integrate Inflammation, Immunity and Metabolism
Current Nutrition & Food Science Serum Procalcitonin Levels in Febrile Patients with Systemic Autoimmune Diseases
Current Rheumatology Reviews MicroRNA-136 Promotes Vascular Muscle Cell Proliferation Through the ERK1/2 Pathway by Targeting PPP2R2A in Atherosclerosis
Current Vascular Pharmacology Proteasome Inhibition in Transplantation-Focusing on the Experience with Bortezomib
Current Pharmaceutical Design Update on ICOS: A Possible Target for Turning-Off Autoimmunity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) N6-methyladenine RNA Modification (m<sup>6</sup>A): An Emerging Regulator of Metabolic Diseases
Current Drug Targets Relaxin Receptors - New Drug Targets for Multiple Disease States
Current Drug Targets Application of Gene Therapy in Diabetes Care
Infectious Disorders - Drug Targets Melatonin in Pregnancy: Effects on Brain Development and CNS Programming Disorders
Current Pharmaceutical Design Serotonin and Cancer: What Is the Link?
Current Molecular Medicine Cell Penetrating Peptides for In Vivo Molecular Imaging Applications
Current Pharmaceutical Design Targeting Tyrosine Kinase Receptors in Hepatocellular Carcinoma
Current Cancer Drug Targets